Mesenchymal Stem Cells In Neurodegenerative Disease Therapy is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Mesenchymal stem/stromal cells (MSCs) have emerged as a promising therapeutic approach for neurodegenerative diseases. These multipotent cells can be derived from various tissues and exert neuroprotective effects through multiple mechanisms. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000034 | stem cell |
Paracrine signaling
Immunomodulation
Mitochondrial transfer
| Method | Advantages | Challenges | [2]
|--------|------------|------------|
| Intravenous | Non-invasive | BBB penetration |
| Intrathecal | Direct CNS access | Invasive |
| Intraparenchymal | Targeted delivery | Surgical risk |
The study of Mesenchymal Stem Cells In Neurodegenerative Disease Therapy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
](/diseases/neurodegeneration-treatments)##